{
  "authors": [
    {
      "author": "Seyed Hamzeh Hosseini"
    },
    {
      "author": "Ebrahim Salehifar"
    }
  ],
  "doi": "10.1186/1757-1626-2-9340",
  "publication_date": "2010-01-13",
  "id": "EN117933",
  "url": "https://pubmed.ncbi.nlm.nih.gov/20066059",
  "source": "Cases journal",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "A 27 year-old male patient was suffering from dysthymia for 6 years. He received different kinds of pharmacotherapy including TCAs, SSRIs, MAOIs. Due to his poor response, augmenting therapy with liothyronine and lithium and also cognitive therapy have been tried for him. Since he did not respond well to these treatments, maprotiline was administered for him 50 mg daily. His psychological problems improved with maprotiline, however he experienced social phobia that has not experienced yet."
}